|Articles|December 27, 2001

Influenza Antiviral Reduces Infection Rate

CHICAGO-Researchers at the Interscience Conference on Antimicrobial Agents and Chemotherpay (ICAAC) reported a new influenza medication limits the spread of the infectious disease within households.

The Family Influenza Transmission (FIT) study was presented at the conference, showing that simultaneous treatment of the person initially infected, along with prophylaxis treatment of other household members, protected those not infected in 63% of households. Tamiflu, known as oseltamivir phosphate generically, has shown to reduce flu-like symptoms and reduce the ability of the virus to infect others.

Tamiflu is a Roche Laboratory product.

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Related to this article

Randalyn Harreld, CRCST, CIS, CER, CHL, CSPDT, CASSPT, CLS, AAS, FHSPA, clinical education manager for Steelco Belimed

September 21st, 2026

Sterile Processing Burnout and Cognitive Overload: How Interruptions, IFUs, and Human Factors Affect Patient Safety

Sterile processing professionals face constant interruptions, cognitive overload, increasingly complex devices, and hundreds of IFUs. Randalyn Harreld, CRCST, FHSPA, explains why health care organizations must address the human factors behind SPD performance rather than expecting frontline professionals to simply absorb ever-increasing complexity.

HIV virus (Adobe Stock 3483234 by Yang MingQi)

September 21st, 2026

Long-Acting HIV Treatment and PrEP: How Weekly Oral and Injectable Therapies Could Change Adherence and Patient Choice

Long-acting HIV therapies promise greater convenience, but fewer doses alone may not solve adherence or access challenges. Lloyd Bibby and Pooja Goyal, MS(Pharm), discuss patient choice, weekly oral and injectable therapies, health system capacity, equitable access, and the real-world measures that will define success.

Weekly Rounds With Infection Control Today

September 18th, 2026

ICT Weekly Rounds – September 17, 2026: RIngworm, Measles, Ebola Updates

This week on Infection Control Today, the stories ranged from emerging drug-resistant pathogens circling the globe to a landmark decade of surface science—all against a backdrop of ongoing outbreaks and a hard look at what the profession owes its own workforce.

Stacy Palmer, senior vice president and chief operating officer of The Beryl Institute (Image credit: author)

September 17th, 2026

AHE 2026: Stacy Palmer Explains How EVS Shapes Patient and Human Experience in Health Care

At AHE 2026 in New Orleans, The Beryl Institute's Stacy Palmer discussed 8 guiding principles for experience excellence and why EVS professionals influence far more than environmental cleanliness. Their interactions, workplace culture, and connection with patients help shape the overall human experience of health care.

Fungal infection called Trichophyton indotineae in thigh of child. Ringworm. (Adobe Stock by ZAY WIN HTAI)

September 17th, 2026

What Is Trichophyton indotineae? Drug-Resistant Ringworm Spreads to 29 Countries

Drug-resistant Trichophyton indotineae has now been identified in 29 countries. Its resistance to first-line terbinafine, resemblance to other dermatophytes, and expanding global transmission are creating new challenges for diagnosis, treatment, surveillance, and antifungal stewardship.

The cover of the September 2026 digital issue of Infection Control Today.

September 16th, 2026

Infection Control Today Launches First Digital Magazine for Infection Prevention Professionals

Infection Control Today celebrates 30 years of covering the people, science, and challenges shaping infection prevention with another milestone: its first digital magazine, featuring outbreak analysis, biosecurity, respiratory testing, sterile processing, professional leadership, conference coverage, and more.

A nurse and an EVS professional walk down a hospital hallway. (Image credit: Brenna Doran with AI)

September 16th, 2026

National EVS Week 2026: Why Environmental Services Is Essential to Infection Prevention and Patient Safety

During National EVS Week, appreciation matters, but partnership matters more. Environmental services professionals bring infection prevention expertise and a unique understanding of the health care environment that can help identify barriers, improve cleaning and disinfection practices, and ultimately protect patients.

Infection preventionists in full PPE with children in DRC. (Image credit: author with AI)

September 15th, 2026

Chasing the Bundibugyo Outbreak: How Static Numbers Hide a Moving Epidemic

Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.